926MO MK-1084 monotherapy in participants (Pts) with KRAS G12C–mutated advanced solid tumors: Activity and safety in the phase I KANDLELIT-001 study. - Simonelli, M.; Rojas, C.I.; Dziadziuszko, R.; Park, J.O.; Xue, J.; Felip, E.; Moreno Garcia, V.; Bar, J.; Lakhani, N.; Kwiatkowski, M.; Ahern, E.S.; Lee, J.; et al. (Annals of Oncology, 2025)